![]() |
||
Ali Naini, PhD, MS
Associate Professor of Clinical Pathology and Cell Biology Director, Laboratories of Metabolic and Mitochondrial Diseases Departments of Pathology & Cell Biology and Neurology Email: abn2@columbia.edu Education:
Diplomat, American Board of Clinical Chemistry 1994 American Society of Clinical Pathologists 1990 National Registry in Clinical Chemistry: Clinical Chemist 1989 Office Location: 630 W 168th Street, P&S 17th Floor, Room 401 New York, NY 10032 Office Telephone: 212-305-3947 Affiliations: » The Merritt Center Laboratory of Molecular Neurogenetics » Recent Publications Research Summary Dr. Ali Naini is an Associate Professor of Clinical Pathology and Cell Biology and Director of Laboratory of Molecular Neurogenetics in the Department of Neurology and a member of Houston Merritt Center for Clinical Research. Dr. Naini's research interests include molecular pathogenesis of neurodegenerative diseases and primary CoQ defeiciency. In collaboration with Drs. Hiroshi Mitsumoto, Michio Hirano, and Serge Przedborski, Dr. Naini studies patients affected with amyotrophic lateral sclerosis (Lou Gehrig's Disease) harboring mutations in their Cu/Zn superoxide dismutase gene. In collaboration with Drs. Savatore DiMauro, and Michio Hirano, he also studies patients with mitochondrial encephalomyopathy due to primary CoQ deficiency. Dr. Naini is board certified clinical biochemist and molecular geneticist. He received his graduate training at London University and University of Surrey in the United Kingdom. Dr. Naini joined Neuromuscular group at Houston Merritt Center in 1997 as the director of the Laboratory of Molecular Neurogenetics and Mitochondrial Diseases. Dr. Naini is a regular reviewer of several international journals and is author and co-author of numerous publications related to the pathogenesis and molecular aspects of neurological diseases. © 2012 The Neurological Institute of New York • 710 W 168th St, New York, NY 10032 Department of Neurology | Columbia University Medical Center | Last updated: December 4, 2012 | Comments |